Provider teams outperform solo care for new-onset chronic disease

Provider teams outperform solo care for new-onset chronic disease

(HealthDay)—Provider teams outperform solo providers for management of three new-onset chronic diseases, while among solo providers, care management and outcome differ little between physicians and nonphysicians, according to a report published in the March issue of Health Affairs.

Maximilian J. Pany, from Harvard Medical School in Boston, and colleagues used electronic health record data from U.S. primary care practices to examine how care management and biomarker outcomes after new onset of three chronic diseases (type 2 , hyperlipidemia, and hypertension) differed by team-based versus solo care and by care from a physician versus nonphysician ( and physician assistant).

The researchers found that irrespective of the team composition, provider teams outperformed solo providers. When receiving an abnormal biomarker result, provider teams submitted diagnostic claims at significantly higher rates than solo providers for type 2 diabetes mellitus and hypertension, but at similar rates for hyperlipidemia. Provider teams were also more likely than solo providers to have patients whose disease was under control for all three . Among solo providers, there was little meaningful difference in performance for physicians and nonphysicians.

"Our findings demonstrate improved performance of provider teams over solo providers," the authors write. "To improve primary care outcomes, should consider a set of interventions that could encourage team formation and practice, such as innovative primary care delivery models and value-based payment reform that rewards collaboration."

Explore further

VA study backs use of physician assistants, nurse practitioners in diabetes care

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Health Affairs

Copyright © 2020 HealthDay. All rights reserved.

Citation: Provider teams outperform solo care for new-onset chronic disease (2021, March 2) retrieved 14 April 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments